Aquestive Therapeutics, Inc.AQ.STNASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank43
Year-over-Year Change
Year-over-year free cash flow growth rate
Percentile
P43
Within normal range
vs 5Y Ago
-0.5x
Contraction
Streak
2 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -32.61% |
| 2024 | 38.79% |
| 2023 | 1008.75% |
| 2022 | -273.91% |
| 2021 | -90.54% |
| 2020 | 64.17% |
| 2019 | 2462.08% |
| 2018 | -72.15% |
| 2017 | -75.41% |
| 2016 | 98.48% |